Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss
Authors
Keywords
-
Journal
ACTA NEUROPATHOLOGICA
Volume 123, Issue 6, Pages 861-872
Publisher
Springer Nature
Online
2012-04-21
DOI
10.1007/s00401-012-0986-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Functional Consequences of Neuromyelitis Optica-IgG Astrocyte Interactions on Blood-Brain Barrier Permeability and Granulocyte Recruitment
- (2014) T. Vincent et al. JOURNAL OF IMMUNOLOGY
- Complement-dependent Cytotoxicity in Neuromyelitis Optica Requires Aquaporin-4 Protein Assembly in Orthogonal Arrays
- (2012) Puay-Wah Phuan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Aquaporin-4: orthogonal array assembly, CNS functions and role in neuromyelitis optica
- (2011) Alan S Verkman et al. ACTA PHARMACOLOGICA SINICA
- Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms
- (2011) Hua Zhang et al. ANNALS OF NEUROLOGY
- Anti-Aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica
- (2011) Lukmanee Tradtrantip et al. ANNALS OF NEUROLOGY
- Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain
- (2011) Samira Saadoun et al. ANNALS OF NEUROLOGY
- Antibody-Dependent Cell Cytotoxicity Synapses Form in Mice during Tumor-Specific Antibody Immunotherapy
- (2011) P. Hubert et al. CANCER RESEARCH
- Proinflammatory role of aquaporin-4 in autoimmune neuroinflammation
- (2011) Lihua Li et al. FASEB JOURNAL
- Evidence against Cellular Internalizationin Vivoof NMO-IgG, Aquaporin-4, and Excitatory Amino Acid Transporter 2 in Neuromyelitis Optica
- (2011) Julien Ratelade et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Clinical Cancer Therapy by NK Cells via Antibody-Dependent Cell-Mediated Cytotoxicity
- (2011) Kory L. Alderson et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Genetic Deletion of Cdc42 Reveals a Crucial Role for Astrocyte Recruitment to the Injury Site In Vitro and In Vivo
- (2011) S. Robel et al. JOURNAL OF NEUROSCIENCE
- Intravenous Neuromyelitis Optica Autoantibody in Mice Targets Aquaporin-4 in Peripheral Organs and Area Postrema
- (2011) Julien Ratelade et al. PLoS One
- Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice
- (2010) Samira Saadoun et al. BRAIN
- Involvement of neutrophils and natural killer cells in the anti-tumor activity of alemtuzumab in xenograft tumor models
- (2010) William M. Siders et al. LEUKEMIA & LYMPHOMA
- AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance
- (2010) Sven Jarius et al. Nature Reviews Neurology
- Complement in neuroprotection and neurodegeneration
- (2010) Vijay Yanamadala et al. TRENDS IN MOLECULAR MEDICINE
- Intrathecal pathogenic antiâaquaporin-4 antibodies in early neuromyelitis optica
- (2009) Jeffrey L. Bennett et al. ANNALS OF NEUROLOGY
- Prediction of Neuromyelitis Optica Attack Severity by Quantitation of Complement-Mediated Injury to Aquaporin-4–Expressing Cells
- (2009) Shannon R. Hinson et al. ARCHIVES OF NEUROLOGY
- Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies
- (2009) Grazia Paola Nicchia et al. GLIA
- Determinants of aquaporin-4 assembly in orthogonal arrays revealed by live-cell single-molecule fluorescence imaging
- (2009) J. M. Crane et al. JOURNAL OF CELL SCIENCE
- Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: An in vitro study
- (2009) Lidia Sabater et al. JOURNAL OF NEUROIMMUNOLOGY
- Neurological autoimmunity targeting aquaporin-4
- (2009) S.R. Hinson et al. NEUROSCIENCE
- Natural Killer Cells in Innate Immunity and Cancer
- (2008) Brian Becknell et al. JOURNAL OF IMMUNOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started